Loring Wolcott & Coolidge Fiduciary Advisors LLP Neogenomics Inc Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 08, 2018	SELL	$8.02 - $11.18 $882 - $1,229	-110 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$9.11 - $11.26 $1,002 - $1,238	110	110 $1,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$333 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$238 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$117 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$112 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$111 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account